论文部分内容阅读
目的观察低分子肝素钙、酚妥拉明联用对肺心病顽固性心衰的疗效。方法在原有治疗肺心病的基础上给64例患者加用酚妥拉明10mg,加入5%葡萄糖注射液250m l,以10~15滴/m in静脉滴注;低分子肝素钙5000 IU,腹部皮下注射,每日2次,7~10d为1个疗程,对心功能改善情况及治疗前后血压、心率、24h尿量改变进行观察。结果治疗1个疗程后心功能改善总有效率达93.7%。结论低分子肝素钙、酚妥拉明联用对肺心病顽固性心衰为又一安全有效的治疗方法。
Objective To observe the effect of low molecular weight heparin calcium and phentolamine on refractory heart failure with pulmonary heart disease. Methods Sixty-four patients were treated with phentolamine 10 mg and 250 ml of 5% dextrose injection on the basis of the original treatment of pulmonary heart disease. The low molecular weight heparin 5000 IU Subcutaneous injection, 2 times a day, 7 ~ 10d for a course of treatment, improve cardiac function and blood pressure before and after treatment, heart rate, 24h urine output were observed. Results After a course of treatment, the total effective rate of heart function improvement was 93.7%. Conclusion Low molecular weight heparin, phentolamine combined with refractory heart failure of pulmonary heart disease is another safe and effective treatment.